Hernia reduction following laparotomy using small stitch abdominal wall closure with and without mesh augmentation (the HULC trial): study protocol for a randomized controlled trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
16 Dec 2019
Historique:
received: 23 08 2019
accepted: 19 11 2019
entrez: 18 12 2019
pubmed: 18 12 2019
medline: 1 9 2020
Statut: epublish

Résumé

Incisional hernias are among the most frequent complications following abdominal surgery and cause substantial morbidity, impaired health-related quality of life and costs. Despite improvements in abdominal wall closure techniques, the risk for developing an incisional hernia is reported to be between 10 and 30% following midline laparotomies. There have been two recent innovations with promising results to reduce hernia risks, namely the small stitches technique and the placement of a prophylactic mesh. So far, these two techniques have not been evaluated in combination. The HULC trial is a multicentre, randomized controlled, observer- and patient-blinded surgical effectiveness trial with two parallel study groups. A total of 812 patients scheduled for elective abdominal surgery via a midline laparotomy will be randomized in 12 centres after informed consent. Patients will be randomly assigned to the control group receiving closure of the midline incision with a slowly absorbable monofilament suture in the small stitches technique or to the intervention group, who will receive a small stitches closure followed by augmentation with a light-weight polypropylene mesh in the onlay technique. The primary endpoint will be the occurrence of incisional hernias, as defined by the European Hernia Society, within 24 months after surgery. Further perioperative parameters, as well as patient-reported outcomes, will be analysed as secondary outcomes. The HULC trial will address the yet unanswered question of whether a combination of small stitched fascial closure and onlay mesh augmentation after elective midline laparotomies reduces the risk of incisional hernias. The HULC trial marks the logical and innovative next step in the development of a safe abdominal closure technique. German Clinical Trials Register, DRKS00017517. Registered on 24th June 2019.

Sections du résumé

BACKGROUND BACKGROUND
Incisional hernias are among the most frequent complications following abdominal surgery and cause substantial morbidity, impaired health-related quality of life and costs. Despite improvements in abdominal wall closure techniques, the risk for developing an incisional hernia is reported to be between 10 and 30% following midline laparotomies. There have been two recent innovations with promising results to reduce hernia risks, namely the small stitches technique and the placement of a prophylactic mesh. So far, these two techniques have not been evaluated in combination.
METHODS METHODS
The HULC trial is a multicentre, randomized controlled, observer- and patient-blinded surgical effectiveness trial with two parallel study groups. A total of 812 patients scheduled for elective abdominal surgery via a midline laparotomy will be randomized in 12 centres after informed consent. Patients will be randomly assigned to the control group receiving closure of the midline incision with a slowly absorbable monofilament suture in the small stitches technique or to the intervention group, who will receive a small stitches closure followed by augmentation with a light-weight polypropylene mesh in the onlay technique. The primary endpoint will be the occurrence of incisional hernias, as defined by the European Hernia Society, within 24 months after surgery. Further perioperative parameters, as well as patient-reported outcomes, will be analysed as secondary outcomes.
DISCUSSION CONCLUSIONS
The HULC trial will address the yet unanswered question of whether a combination of small stitched fascial closure and onlay mesh augmentation after elective midline laparotomies reduces the risk of incisional hernias. The HULC trial marks the logical and innovative next step in the development of a safe abdominal closure technique.
TRIAL REGISTRATION BACKGROUND
German Clinical Trials Register, DRKS00017517. Registered on 24th June 2019.

Identifiants

pubmed: 31842966
doi: 10.1186/s13063-019-3921-3
pii: 10.1186/s13063-019-3921-3
pmc: PMC6915967
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

738

Subventions

Organisme : Deutsche Forschungsgemeinschaft (DE)
ID : 410901776

Références

Ann Surg. 2015 Feb;261(2):276-81
pubmed: 24983993
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Am J Surg. 1996 Oct;172(4):328-31
pubmed: 8873523
Hernia. 2003 Sep;7(3):134-6
pubmed: 12687426
Obstet Gynecol. 1997 May;89(5 Pt 1):684-9
pubmed: 9166301
Ann Chir. 1995;49(6):544-8
pubmed: 8526449
Stat Med. 1999 Aug 15;18(15):1905-42
pubmed: 10532877
Langenbecks Arch Surg. 2019 May;404(3):273-284
pubmed: 30824993
Ann Surg. 2015 May;261(5):876-81
pubmed: 25575254
Hernia. 2016 Dec;20(6):819-830
pubmed: 26932743
J Surg Res. 2016 Jun 15;203(2):378-82
pubmed: 27363646
Am J Surg. 1996 Jan;171(1):80-4
pubmed: 8554156
J Am Coll Surg. 2001 Oct;193(4):392-5
pubmed: 11584967
Arch Surg. 2009 Nov;144(11):1056-9
pubmed: 19917943
Lancet. 2015 Sep 26;386(10000):1254-1260
pubmed: 26188742
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Br J Surg. 2014 Jan;101(2):51-4
pubmed: 24281948
Hernia. 2018 Apr;22(2):319-324
pubmed: 29349615
Br J Surg. 2006 Nov;93(11):1347-50
pubmed: 17006977
Clin Trials. 2008;5(3):225-39
pubmed: 18559412
Hernia. 2015 Feb;19(1):1-24
pubmed: 25618025
Br J Surg. 2010 Oct;97(10):1497-502
pubmed: 20603858
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Hernia. 2012 Apr;16(2):179-83
pubmed: 21904861
Ann Surg. 2010 May;251(5):843-56
pubmed: 20395846
Dig Surg. 2013;30(4-6):401-9
pubmed: 24217341
N Engl J Med. 2000 Aug 10;343(6):392-8
pubmed: 10933738
Langenbecks Arch Surg. 2012 Dec;397(8):1201-7
pubmed: 23143146
Cochrane Database Syst Rev. 2017 Nov 03;11:CD005661
pubmed: 29099149
Clin Trials. 2016 Aug;13(4):456-8
pubmed: 26908545
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Ann Surg. 2016 Apr;263(4):638-45
pubmed: 26943336
Br J Surg. 2005 Oct;92(10):1208-11
pubmed: 16175532
Ann Surg. 2009 Apr;249(4):576-82
pubmed: 19300233
Lancet. 2017 Aug 5;390(10094):567-576
pubmed: 28641875
Am J Surg. 2012 Aug;204(2):144-50
pubmed: 22579232
Ann Surg. 2003 Jan;237(1):129-35
pubmed: 12496540
Front Surg. 2016 Sep 26;3:53
pubmed: 27725931
Ann Intern Med. 2010 Jun 1;152(11):726-32
pubmed: 20335313
Lancet. 2014 Jul 12;384(9938):142-52
pubmed: 24718270
Am J Infect Control. 1999 Apr;27(2):97-132; quiz 133-4; discussion 96
pubmed: 10196487
Hernia. 2009 Jun;13(3):267-74
pubmed: 19262985
Arch Surg. 1992 Oct;127(10):1232-4
pubmed: 1417492

Auteurs

Patrick Heger (P)

Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
The Study Center of the German Surgical Society (SDGC), University Hospital Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

Manuel Feißt (M)

Institute of Medical Biometry and Informatics (IMBI), University of Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

Johannes Krisam (J)

Institute of Medical Biometry and Informatics (IMBI), University of Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

Christina Klose (C)

Institute of Medical Biometry and Informatics (IMBI), University of Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

Colette Dörr-Harim (C)

Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
The Study Center of the German Surgical Society (SDGC), University Hospital Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

Solveig Tenckhoff (S)

The Study Center of the German Surgical Society (SDGC), University Hospital Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

Markus W Büchler (MW)

Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.

Markus K Diener (MK)

Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
The Study Center of the German Surgical Society (SDGC), University Hospital Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

André L Mihaljevic (AL)

Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany. andre.mihaljevic@med.uni-heidelberg.de.
The Study Center of the German Surgical Society (SDGC), University Hospital Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. andre.mihaljevic@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH